Japanese encephalitis (JE) is a mosquito-borne disease with Background: high case fatality and no specific treatment. Little is known about the community's (especially parents/guardians of children) awareness regarding JE and its vaccine in Yangon region, which bears the highest JE burden in Myanmar.
Introduction
Japanese encephalitis (JE) is a zoonotic disease caused by Japanese encephalitis virus (JEV). JEV exists in a transmission cycle between mosquitoes, pigs and/or water birds and is transmitted to humans through bites from infected mosquitoes of the Culex species (mainly Culex tritaeniorhynchus) 1 . JE usually presents as acute encephalitis syndrome (AES) and is confirmed by serology.
JE is a disease of public health importance as billions of people are at risk of getting infected by JEV and children below 15 years are more susceptible 1 . A systematic review (2011) reported that 67,900 clinical cases of JE occur annually in 24 Asian and western Pacific countries despite the widespread availability of the vaccine, with approximately 13,600 to 20,400 deaths. While the overall incidence of JE is 1.8 per 100,000 per year in endemic countries, it is 5.4 among 1-15 year-old children 2 . The infection can lead to severe complications with high case fatality. There is no specific treatment to date. JE is not easily prevented by protection from mosquito control and mosquito bites. Hence, vaccination is the most effective form of prevention 1 . Globally, live attenuated SA 14-14-2 JE vaccine is the most commonly used JE vaccine. Vaccine efficacy is reported to be between 80% and 99% following single-dose vaccination and 98% or greater with two doses 3 .
In Myanmar, Culex tritaeniorhynchus is the main JE vector 4 . In 2012, there were only 14 confirmed JE cases, which increased to 151 in 2015 and more than 380 in 2016 and 2017, indicative of improved surveillance in the country 5 .
In 2017, the Expanded Programme on Immunization (EPI) under the Department of Public Health carried out a nationwide JE vaccination catch-up campaign supported by the GAVI, WHO, the United Nations Children's Fund and PATH. In November and December, nearly 14 million children (aged nine months to 15 years) were targeted and vaccinated with the WHO live attenuated (SA 14-14-2) JE vaccine. Alongside the campaign there were extensive advocacy and sensitization sessions provided to schools and communities 6 . Since January 2018, immediately after the JE campaign, routine immunization in Myanmar has included JE live attenuated vaccine, given at the age of nine months together with the measles-rubella vaccine.
Adequate knowledge of JE and a positive perception of the JE vaccine are important for the adoption of preventive measures 7 . In addition, high coverage of the JE vaccine in populations at risk of disease is required to reduce the JE cases because JE vaccination would not provide herd immunity 8 . A study conducted in one township in northern Shan state in Myanmar (2018) showed the level of awareness of JE and its vaccine was low but the perception towards knowledge of JE was generally positive 9 . The vaccination coverage was 93% among 391 study participants.
Little is known about the community's (especially parents/ guardians of children) awareness regarding JE and its vaccine in Yangon region, which bears the highest JE burden in the country 6 . This data, alongside vaccination coverage data for children, may help the regional vector borne disease control (VBDC) programme and EPI to develop a new coordinated strategic plan to successfully reduce JE transmission in Yangon region. Therefore, in Yangon region, we aimed to describe the i) knowledge and perception of the parents/guardians of children (1-15 years old) towards JE disease and vaccine, and ii) JE vaccine coverage among 1-15 year-old children.
Methods

Ethical statement
The Ethics Review Committee, Department of Medical Research, Myanmar (Ethics/DMR/2018/102EA/2019/028) and the Union Ethics Advisory Group of the International Union against Tuberculosis and Lung Disease (The Union), Paris, France (EAG 04/19) approved the study. Written informed consent for participation in the survey was taken from the parents/guardians of children aged 1-15 years old and the consent process was approved by the ethics committees.
Study design
This was a community-based cross-sectional survey involving primary data collection.
Study setting
Myanmar is located in the Southeast Asia region, neighboring Laos to the east, Bangladesh to the west, Thailand to the southeast, the Republic of China to the north and northeast and India to the northwest. Myanmar has a population of 51 million with an urban:rural population ratio of 30:70. The country has 14 states and regions including Nay Pyi Taw council territory. It consists of 74 districts, 330 townships, 398 towns, 3065 wards, 13,619 village tracts and 64,134 villages 10 .
Yangon is the economic capital of Myanmar with four districts, 46 townships, 743 wards and 628 village tracts. The population of Yangon region is the highest in size when compared with other states and regions in the country. The urban:rural population ratio is 70:30 10 .
Study population
The study population included parents/guardians of children (1-15 years old) living in Yangon region for the first objective and children (1-15 years old) for the second objective (February to June 2019).
Sample size and sampling procedure
For the first two objectives, assuming that the prevalence of community awareness of JE and its vaccination among parents/guardians of children (1-15 years old) and vaccination coverage of children (1-15 years old) in Yangon being 50% with 5% precision at 95% CI, the calculated sample size was 384. Assuming a non-response rate of 5% and a design effect of 1.5, the final sample size was 600 households with children (1-15 years old) We used the conservative assumption of 50% prevalence as there is no previous data on community awareness and vaccination coverage in Yangon region and 5% non-response rate based on field experience.
We used three stage random sampling to sample the 600 households with children (1-15 years) from 30 clusters (ward or village tract) in nine townships in Yangon region (see Figure 1 and Figure 2 ). In the first two stages, we used stratified random sampling and in the third stage, we used systematic random sampling. First, we randomly selected the nine townships after stratifying them into urban, rural and mixed based on the classification used in population census in Myanmar 10 . Then, in the second stage, we randomly selected 30 clusters after stratifying them into wards and village tracts in each selected township. Within each township, trained field assistants went directly to the general administration department for a list of the households and map of the selected wards/village tracts. The trained field assistants conducted systematic random sampling to select 20 households with children aged 1-15 years old within each cluster. The trained field assistants chose a random starting point using the map and then selected the first household. Then, they went to next household using the sampling interval until the required sample size was reached. Sampling interval was calculated by dividing the total number of household in the selected wards or village tracts by the required sample size for that selected wards or village tracts. If the selected household did not have any children aged 1-15 years old, field assistants went to the next adjacent household with a child in this age range. If the selected house was locked or there was no parent or guardian, field assistants followed the same procedure as above. In case the selected house was an apartment building, we selected one household randomly. We interviewed the parent or guardian of the child available at the time of survey, preferably the mother.
Data collection and tools
During February-June 2019, at the selected households, field assistants conducted face to face interviews with parents/guardians using a pretested structured questionnaire (see Annex 1 and Annex 3, Extended data) 11, 12 . The field assistant asked the questions verbally to the participants and completed the questionnaires. The structured questionnaires were tested during a pilot survey and were revised according to feedback received during the pilot survey.
The questionnaire consisted of four sections. The first section highlighted the socio-demographic information. The second section was comprised of 12 questions that assessed the knowledge of participants about JE disease and prevention (including vaccination). The third section assessed perception. The fourth section included information about vaccination status of the children. If the selected household had more than one child aged 1-15 years old, we asked the parent/guardian about the vaccination status of all the children in this age range. Vaccination status was based on parents' or guardians' recall. Field assistants also asked about the presence or absence of a vaccination card.
Data management and analysis
Data from the survey forms were double-entered and validated using EpiData entry software (version 3.1, EpiData Association, Odense, Denmark). Data were analyzed using STATA (version 12.1, STATA Corp., College Station, TX, USA). There were no missing data in the study.
We provided weighted estimates as the analyses were weighted (inverse probability sampling) for the multi-stage sampling design. We used frequency and proportion to summarize the characteristics of the study participants. We assigned a knowledge score to each participant based on the number of correct or appropriate responses. Each appropriate answer was assigned one point and incorrect responses or "do not know" were assigned zero points. The scores were further dichotomized into poor or good (0-6 as poor and 7-12 as good). No overall score was calculated for perception. Vaccine coverage was calculated by the number of children that received JE vaccination (either during campaign or routine immunization) divided by the total number of children and presented as proportion and 95% confidence interval (CI).
Results
The socio-demographic characteristics of 600 parents/guardians are presented in Table 1 13 . Among them, 1% were aged ≤ 20 years, 4% were aged >60 years and 74% were female. A total of 50% had a high school or graduate level education and 29% had a monthly family income of more than $285 USD.
Knowledge and perception
Overall, 37.6% exhibited good knowledge of JE. We have depicted the knowledge of respondents regarding cause, transmission, symptoms, prevention and treatment in Table 2 . Among 600 parents/guardians, 49.3% had correct knowledge that JE is a fatal disease. Although 65.3% knew that the JE vaccine was available locally, only 26.8% correctly answered that vaccination is the most effective means to protect against JE.
It was found that 23% did not know the symptoms of JE, 16% responded incorrectly that JE has specific treatment and 58.8% responded that they did not know whether there is a treatment for JE or not. Participants responded that they used mosquito nets (31.3%), mosquito coils (14.1%) and spray or fumigation methods (10.7%) to avoid mosquito bites.
Over half (55%) of participants perceived JE as serious in children younger than 15 years, 59% perceived the vaccine to be effective and 25% perceived JE to be harmful for pig farmers (Figure 3 ). Health care staff (25%) and television (17%) were the main sources of information about JE disease (Figure 4 ). The source of information on JE routine vaccination or campaigns was from school (35.1%), health worker visits (33.1%), announcements made using microphones in the neighborhood (13.9%) and volunteer visits (5.3%).
Vaccine coverage
Among all the children in the 600 households (n=855), 831 were vaccinated. The vaccination coverage was 97.2% (95% CI: 95.9-98.1). Of 831 vaccinated children, 423 (50.9%) were cross-checked through a vaccination card. Of 831 children, 516 (62.1%) received the vaccination during the JE campaign, 234 (28.2%) during routine immunization and 67 (7.8%) received the vaccine twice during both campaign and routine vaccination. Among the 24 children that did not receive vaccination, the main reasons were: parents or guardians did not realize the importance of JE vaccination (n=4), the child was sick at the time of immunization (n=3), the parents/guardians did not know about the JE vaccination (n=2) and travel (n=6).
Discussion
In this region-wide survey on JE and its vaccine coverage in Yangon, Myanmar, the majority of parents or guardians did not have good knowledge of JE. Perception of the seriousness of JE disease was poor in half of participants. Vaccination coverage was excellent.
Strengths and limitations
Data were robust as double entry and validation minimized data entry errors. Only one attempt was made to visit each household, which may impact the generalizability of the results as the households with parents and guardians who were working during the survey visit might be missed. Half of parents/guardians did not produce a vaccination card (JE routine immunization or campaign) and recall bias cannot be ruled out. However, as JE vaccination is through an injection (subcutaneous) at a specific site (in the right upper arm) and the vaccination campaign was implemented only once in 2017, we do not think this is a serious limitation.
Key findings and comparison with other studies
We found that parents/guardians had poor knowledge of JE. This finding is similar to the study conducted in a slum of Kolkata by Dasgupta et al. (2016) , which showed that 56.7% of mothers had poor knowledge 14 . Our study showed that 39.5% of participants knew that JE is caused by mosquito bites, which is higher than the 25.6% reported by Dasgupta et al. 14 
.
In our study, the majority of participants showed a lack of knowledge about treatment of the disease, which is similar to a study from India (2015) by Ahmad et al. 7 .
More than half of the participants perceived JE as serious in children younger than 15 years old, but they did not perceive pig farming as contributing to the threat of JE. This is similar to the study in India, where respondents did not perceive pig farming as contributing to the threat of JE 15 . Possible reasons for poor knowledge and perception of participants was that communities did not think of JE as a possible threat like other vector-borne diseases such as dengue and malaria. Implications JE cases in Yangon region have declined in 2018 and 2019 compared to earlier years. In January -August 2019, there were only 244 AES cases and 12 confirmed JE cases 19 . To sustain this decline, high vaccination coverage, health education on JE and effective vector control activity should be maintained. There is a possibility that the high coverage may not be maintained in the long term. This is because within 16-20 months of JE campaign, many were not aware of JE or its vaccine. Hence, steps should be taken in this direction.
Authorities should encourage retention of cards or records of vaccination so unvaccinated children can be identified and vaccinated in future.
Conclusions
JE vaccination coverage was excellent in Yangon region, Myanmar, despite the majority of parents/guardians having poor knowledge and perception of JE disease, its prevention and vaccination. In order to reduce JE incidence in community, a focus on an intensified education program is necessary to sustain the high vaccine coverage in the community. Data are available under the terms of the Creative Commons Zero "No rights reserved" data waiver (CC0 1.0 Public domain dedication).
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